April 20, 2014 3:56 PM ET

Biotechnology

Company Overview of Sequus Pharmaceuticals, Inc.

Executive Profile

I. Craig Henderson M.D.

AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

71--

Background

Dr. I. Craig Henderson, M.D. has been Chief Executive Officer and President of ACCESS Oncology (the private biotechnology company that Keryx Biopharmaceuticals Inc. acquired in February 2004) since January 2001. Dr. Henderson has also been Senior Consultant of Alza Pharmaceuticals since 1999. Dr. Henderson served as President of Keryx Biopharmaceuticals Inc. from March 11, 2004 to April 15, 2008. He served as Chief Executive Officer of Sequus Pharmaceuticals, Inc. from ...

Corporate Headquarters

960 Hamilton Court
Menlo Park, California 94025

United States

Phone: 650-323-9011
Fax: 650-323-9160

Board Members Memberships

1993-1999
Chairman and Chief Executive Officer
1999-N/A
Director and Senior Medical Adviser
2004-2008
Former Director

Education

MD
Columbia University
BA
Grinnell College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sequus Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.